Relay Therapeutics, Inc.
US ˙ NasdaqGM ˙ US75943R1023

SecurityRLAY / Relay Therapeutics, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership112,843 shares
Latest Disclosed Value $ 1,122,788
Man Group plc reports 29.65% increase in ownership of RLAY / Relay Therapeutics, Inc.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 112,843 shares of Relay Therapeutics, Inc. (US:RLAY) valued at $1,122,788 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 87,037 shares of Relay Therapeutics, Inc.. This represents a change in shares of 29.65% during the quarter. The current value of the position is $1,726,498 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RELAY THERAPEUTICS COM 75943R102 112,843 25,806 29.65 1,123 52.45 0.0020
2026-02-17 2025-12-31 13F RELAY THERAPEUTICS COM 75943R102 87,037 -100,784 -53.66 736 -24.90 0.0013
2025-11-14 2025-09-30 13F RELAY THERAPEUTICS COM 75943R102 187,821 -110,689 -37.08 980 -5.04 0.0017
2025-08-14 2025-06-30 13F RELAY THERAPEUTICS COM 75943R102 298,510 92,789 45.10 1,033 91.82 0.0020
2025-05-15 2025-03-31 13F RELAY THERAPEUTICS COM 75943R102 205,721 32,116 18.50 539 -24.76 0.0014
2025-02-14 2024-12-31 13F RELAY THERAPEUTICS COM 75943R102 173,605 173,605 715 0.0019
2024-11-14 2024-09-30 13F RELAY THERAPEUTICS COM 75943R102 0 -101,365 -100.00 0 -100.00
2024-08-14 2024-06-30 13F RELAY THERAPEUTICS COM 75943R102 101,365 -86,617 -46.08 661 -57.69 0.0017
2024-05-15 2024-03-31 13F RELAY THERAPEUTICS COM 75943R102 187,982 130,635 227.80 1,560 147.23 0.0039
2024-02-14 2023-12-31 13F RELAY THERAPEUTICS COM 75943R102 57,347 57,347 631 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.